{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:31:06Z","timestamp":1779291066662,"version":"3.51.4"},"reference-count":139,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Alpha-fetoprotein (AFP) is a glycoprotein primarily produced by the fetal liver and yolk sac during development. It is a multifaceted biomarker with significant applications in the prenatal screening of congenital abnormalities, cancer, and other disorders. The level of AFP in maternal blood may indicate several obstetric concerns and complications during pregnancy. Atypical AFP levels are commonly utilized as a biomarker for detecting fetal anomalies, placental complications, and other pregnancy-related issues. These findings raise concerns regarding the effectiveness of screening maternal serum alpha-fetoprotein (MS-AFP) as a primary indicator of pregnancy problems and underscore the need for further investigation into the functional role of AFP throughout pregnancy. The measurement of MS-AFP has been utilized for the past four decades. It is anticipated that MS-AFP measurement will continue to be utilized as a component of integrated or sequential tests for chromosomal abnormalities and may serve as a prognostic indicator for adverse obstetric outcomes. Critically, whether AFP functions solely as a passive marker or plays active biological roles in pregnancy physiology and pathology remains unresolved, necessitating additional mechanistic investigation and discourse. This review consolidates critical data from numerous studies on AFP, focusing specifically on its diagnostic and prognostic applications for congenital abnormalities and problems during pregnancy. This review also identifies key research gaps regarding the functional biology of AFP, particularly whether AFP functions as a passive biomarker or an active participant in the pathophysiology of adverse pregnancy outcomes.<\/jats:p>","DOI":"10.3390\/cimb48050534","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:12:54Z","timestamp":1779286374000},"page":"534","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alpha-Fetoprotein as a Biomarker in Pregnancy: From Genetic Disorders to Obstetric Complications"],"prefix":"10.3390","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7959-4010","authenticated-orcid":false,"given":"Shaqraa","family":"Musawi","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Technology, College of Nursing and Health Sciences, Jazan University, Jazan 45142, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/00365515609049266","article-title":"Demonstration of a new protein fraction in serum from the human fetus","volume":"8","author":"Bergstrand","year":"1956","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/153537020122600503","article-title":"Alpha-fetoprotein Structure and Function: Relevance to Isoforms, Epitopes, and Conformational Variants","volume":"226","author":"Mizejewski","year":"2001","journal-title":"Exp. Biol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/adc.2011.213181","article-title":"\u03b1-Fetoprotein","volume":"96","author":"Murray","year":"2011","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1515\/jpme.1997.25.6.476","article-title":"Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFP screening","volume":"25","author":"Cho","year":"1997","journal-title":"J. Perinat. Med."},{"key":"ref_5","first-page":"257","article-title":"Extremely high maternal serum alpha-fetoprotein levels at second-trimester screening","volume":"78","author":"Killam","year":"1991","journal-title":"Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0029-7844(96)00310-9","article-title":"The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications","volume":"88","author":"Waller","year":"1996","journal-title":"Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0301-2115(00)00431-0","article-title":"Biochemical screening for Down syndrome","volume":"92","author":"Cuckle","year":"2000","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/ewjm.173.3.180","article-title":"Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy","volume":"173","author":"Rausch","year":"2000","journal-title":"West. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/01443610500060693","article-title":"Correlation of abnormal second trimester maternal serum alpha-fetoprotein (MSAFP) levels and adverse pregnancy outcome","volume":"25","author":"Kiran","year":"2005","journal-title":"J. Obstet. Gynaecol. J. Inst. Obstet. Gynaecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/pd.646","article-title":"Very low alpha-fetoprotein in Down syndrome maternal serum screening","volume":"23","author":"Muller","year":"2003","journal-title":"Prenat. Diagn."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.1975.03260010040018","article-title":"Alpha-fetoprotein in noneoplastic hepatic disorders","volume":"233","author":"Bloomer","year":"1975","journal-title":"JAMA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/088800101750059828","article-title":"Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood","volume":"18","author":"Schneider","year":"2001","journal-title":"Pediatr. Hematol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.3748\/wjg.15.5976","article-title":"Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma","volume":"15","author":"Shen","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_14","first-page":"5885","article-title":"A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma","volume":"11","author":"Nakabayashi","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1615\/CritRevEukarGeneExpr.v5.i3-4.40","article-title":"The phylogeny of alpha-fetoprotein in vertebrates: Survey of biochemical and physiological data","volume":"5","author":"Mizejewski","year":"1995","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ygeno.2003.09.009","article-title":"Striking differences between the mouse and the human \u03b1-fetoprotein enhancers","volume":"83","author":"Long","year":"2004","journal-title":"Genomics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s13277-013-0904-y","article-title":"Alpha-fetoprotein: A renaissance","volume":"34","author":"Terentiev","year":"2013","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"ref_18","first-page":"979","article-title":"Synthesis of -fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus","volume":"32","author":"Gitlin","year":"1972","journal-title":"Cancer Res."},{"key":"ref_19","first-page":"84","article-title":"The clinical significance of human alpha-fetoprotein","volume":"8","author":"Yachnin","year":"1978","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1021\/bi00294a043","article-title":"Structural analysis of human and bovine alpha-fetoprotein by electron microscopy, image processing, and circular dichroism","volume":"22","author":"Luft","year":"1983","journal-title":"Biochemistry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000217553","article-title":"Evolution of alpha-fetoprotein: Sequence comparisons among AFP species and with albumin species","volume":"9","author":"Baker","year":"1988","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cca.2008.05.010","article-title":"Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications","volume":"395","author":"Debruyne","year":"2008","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_23","first-page":"121","article-title":"An update of biochemical markers of hepatocellular carcinoma","volume":"10","author":"AlSalloom","year":"2016","journal-title":"Int. J. Health Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s13277-010-0134-5","article-title":"Review of the putative cell-surface receptors for alpha-fetoprotein: Identification of a candidate receptor protein family","volume":"32","author":"Mizejewski","year":"2011","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1073\/pnas.73.5.1452","article-title":"Alpha-fetoprotein: The major high-affinity estrogen binder in rat uterine cytosols","volume":"73","author":"Uriel","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0925-4439(01)00079-5","article-title":"Human alpha-fetoprotein as a Zn2+-binding protein. Tight cation binding is not accompanied by global changes in protein structure and stability","volume":"1586","author":"Permyakov","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.it.2022.04.001","article-title":"Immunomodulatory impact of \u03b1-fetoprotein","volume":"43","author":"Munson","year":"2022","journal-title":"Trends Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/clinchem\/37.9.1639","article-title":"Rapid and sensitive chemiluminescent enzyme immunoassay for measuring tumor markers","volume":"37","author":"Nishizono","year":"1991","journal-title":"Clin. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","article-title":"Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma","volume":"28","author":"Hanif","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.talanta.2019.01.012","article-title":"An fluorescent aptasensor for sensitive detection of tumor marker based on the FRET of a sandwich structured QDs-AFP-AuNPs","volume":"197","author":"Zhou","year":"2019","journal-title":"Talanta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"28697","DOI":"10.1021\/acsami.2c09135","article-title":"Simultaneous Homogeneous Fluorescence Detection of AFP and GPC3 in Hepatocellular Carcinoma Clinical Samples Assisted by Enzyme-Free Catalytic Hairpin Assembly","volume":"14","author":"Chen","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.talanta.2018.04.016","article-title":"Digital analysis with droplet-based microfluidic for the ultrasensitive detection of \u03b2-gal and AFP","volume":"186","author":"Tian","year":"2018","journal-title":"Talanta"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"126851","DOI":"10.1016\/j.snb.2019.126851","article-title":"A digital quantification method for the detection of biomarkers on a microfluidic array chip","volume":"298","author":"Tian","year":"2019","journal-title":"Sens. Actuators B Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bios.2018.04.026","article-title":"A graphene oxide-based label-free electrochemical aptasensor for the detection of alpha-fetoprotein","volume":"112","author":"Yang","year":"2018","journal-title":"Biosens. Bioelectron."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1021\/acs.bioconjchem.9b00874","article-title":"Preparation of Aptamer Responsive DNA Functionalized Hydrogels for the Sensitive Detection of \u03b1-Fetoprotein Using SERS Method","volume":"31","author":"Wang","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8877","DOI":"10.1021\/acs.analchem.7b01349","article-title":"Multiplex Immunochips for High-Accuracy Detection of AFP-L3% Based on Surface-Enhanced Raman Scattering: Implications for Early Liver Cancer Diagnosis","volume":"89","author":"Ma","year":"2017","journal-title":"Anal. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"112158","DOI":"10.1016\/j.bios.2020.112158","article-title":"Dual-modal visual\/photoelectrochemical all-in-one bioassay for rapid detection of AFP using 3D printed microreactor device","volume":"158","author":"Li","year":"2020","journal-title":"Biosens. Bioelectron."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bios.2015.06.037","article-title":"A sensitive photoelectrochemical biosensor for AFP detection based on ZnO inverse opal electrodes with signal amplification of CdS-QDs","volume":"74","author":"Xu","year":"2015","journal-title":"Biosens. Bioelectron."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.aca.2009.06.048","article-title":"Microchip-based ELISA strategy for the detection of low-level disease biomarker in serum","volume":"650","author":"Liu","year":"2009","journal-title":"Anal. Chim. Acta"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1021\/acsami.6b16236","article-title":"Enhanced Fluorescence ELISA Based on HAT Triggering Fluorescence \u201cTurn-on\u201d with Enzyme\u2013Antibody Dual Labeled AuNP Probes for Ultrasensitive Detection of AFP and HBsAg","volume":"9","author":"Wu","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Liu, J., Geng, Q., and Geng, Z. (2024). A Route to the Colorimetric Detection of Alpha-Fetoprotein Based on a Smartphone. Micromachines, 15.","DOI":"10.3390\/mi15091116"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/178794a0","article-title":"Identification of a new normal embryonic haemoglobin","volume":"178","author":"Halbrecht","year":"1956","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00016347709156333","article-title":"Maternal serum alpha-feto-protein: Its value in antenatal diagnosis of genetic disease and in obstetrical-gynaecological care","volume":"61","author":"Habib","year":"1977","journal-title":"Acta Obstet. Gynecol. Scand. Suppl."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.1975.tb25399.x","article-title":"Synthesis of alpha-fetoprotein by rat ascites hepatoma cells","volume":"259","author":"Kanai","year":"1975","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1083\/jcb.61.3.823","article-title":"Alpha1-Fetoprotein Biosynthesis During the Growth Cycle of Differentiated Fetal Rat Hepatocytes in Primary Monolayer Culture","volume":"61","author":"Leffert","year":"1974","journal-title":"J. Cell Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1749-6632.1975.tb25400.x","article-title":"Alpha-Fetoprotein and albumin synthesis during the cell cycle","volume":"259","author":"Tsukada","year":"1975","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3349\/ymj.1987.28.3.218","article-title":"Alpha-fetoprotein values in maternal serum and amniotic fluid for prenatal screening of genetic disorders","volume":"28","author":"Kim","year":"1987","journal-title":"Yonsei Med. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1172\/JCI105486","article-title":"Serum alpha-fetoprotein, albumin, and gamma-G-globulin in the human conceptus","volume":"45","author":"Gitlin","year":"1966","journal-title":"J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.1975.tb25398.x","article-title":"Evolution of alpha-fetoprotein serum levels throughout life in humans and rats, and during pregnancy in the rat","volume":"259","author":"Masseyeff","year":"1975","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00000441-199203000-00004","article-title":"Alpha-fetoprotein levels in normal adults","volume":"303","author":"Ball","year":"1992","journal-title":"Am. J. Med. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/00016347709157207","article-title":"Alpha-fetoprotein (AFP) levels in maternal serum and amniotic fluid in singleton pregnant women in their 10th-25th week post last menstrual period","volume":"69","author":"Johansson","year":"1977","journal-title":"Acta Obstet. Gynecol. Scand. Suppl."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.OGX.0000099770.97668.18","article-title":"Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states","volume":"58","author":"Mizejewski","year":"2003","journal-title":"Obstet. Gynecol. Surv."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0002-9378(97)70220-5","article-title":"Diagnostic dilemma with elevated level of \u03b1-fetoprotein in an undiagnosed twin pregnancy with a small discordant holoacardius acephalus","volume":"177","author":"Entezami","year":"1997","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/(SICI)1097-0223(199709)17:9<837::AID-PD157>3.0.CO;2-O","article-title":"Risks for fetal abnormalities after very and moderately elevated AF-AFPs","volume":"17","author":"Crandall","year":"1997","journal-title":"Prenat. Diagn."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.0001-6349.2004.00471.x","article-title":"Reproductive factors and extreme levels of maternal serum alpha-fetoprotein: A population-based study","volume":"83","author":"Lei","year":"2004","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_56","first-page":"368","article-title":"Maternal Age-Dependent and Sex-Related Changes of Gestational Serum Alpha-Fetoprotein","volume":"10","author":"Veress","year":"2009","journal-title":"Fetal Diagn. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/clinchem\/27.1.133","article-title":"Relation between maternal weight and serum alpha-fetoprotein concentration during the second trimester","volume":"27","author":"Haddow","year":"1981","journal-title":"Clin. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/clinchem\/29.3.531","article-title":"Alpha-fetoprotein concentrations in maternal serum: Relation to race and body weight","volume":"29","author":"Crandall","year":"1983","journal-title":"Clin. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9378(88)90497-8","article-title":"Prospective study of an inverse relationship between maternal glycosylated hemoglobin and serum \u03b1-fetoprotein concentrations in pregnant women with diabetes","volume":"159","author":"Baumgarten","year":"1988","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/clinchem\/43.2.333","article-title":"Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups","volume":"43","author":"Benn","year":"1997","journal-title":"Clin. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"hvae106.316","DOI":"10.1093\/clinchem\/hvae106.316","article-title":"A-321 Rethinking the Role of Race in Prenatal AFP Screening for Open Neural Tube Defects","volume":"70","author":"Butler","year":"2024","journal-title":"Clin. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/clinchem\/hvae053","article-title":"Use of Maternal Race and Weight Provides Equitable Performance in Serum Screening for Open Neural Tube Defects","volume":"70","author":"Messerlian","year":"2024","journal-title":"Clin. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ajog.2023.06.018","article-title":"Reconsidering the use of race adjustments in maternal serum screening","volume":"229","author":"Pierre","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/AOG.0000000000005045","article-title":"Reconsidering Race Adjustment in Prenatal Alpha-Fetoprotein Screening","volume":"141","author":"Burns","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0140-6736(20)32076-6","article-title":"From race-based to race-conscious medicine: How anti-racist uprisings call us to act","volume":"396","author":"Plaisime","year":"2020","journal-title":"Lancet Lond. Engl."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1101\/gad.3.4.537","article-title":"Postnatal repression of the alpha-fetoprotein gene is enhancer independent","volume":"3","author":"Camper","year":"1989","journal-title":"Genes Dev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1055\/s-0035-1562930","article-title":"Role of Maternal Serum Alpha-Fetoprotein and Ultrasonography in Contemporary Detection of Spina Bifida","volume":"32","author":"Racusin","year":"2015","journal-title":"Am. J. Perinatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/GIM.0b013e3181bb267b","article-title":"Screening for fetal aneuploidy and neural tube defects","volume":"11","author":"Driscoll","year":"2009","journal-title":"Genet. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00381-003-0784-3","article-title":"Prenatal biochemical screening for neural tube defects","volume":"19","author":"Muller","year":"2003","journal-title":"Childs Nerv. Syst."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"G\u0142owska-Ciemny, J., Szmyt, K., Kuszerska, A., Rzepka, R., von Kaisenberg, C., and Kocy\u0142owski, R. (2024). Fetal and Placental Causes of Elevated Serum Alpha-Fetoprotein Levels in Pregnant Women. J. Clin. Med., 13.","DOI":"10.3390\/jcm13020466"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00125817-200505000-00010","article-title":"Technical standards and guidelines: Prenatal screening for open neural tube defects: This new section on \u201cPrenatal Screening for Open Neural Tube Defects,\u201d together with the new section on \u201cPrenatal Screening for Down Syndrome,\u201d replaces the previous Section H of the American College of Medical Genetics Standards and Guidelines for Clinical Genetics Laboratories","volume":"7","author":"Bradley","year":"2005","journal-title":"Genet. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3468(88)80531-1","article-title":"Maternal serum alpha-fetoprotein is a marker for fetal anomalies in pediatric surgery","volume":"23","author":"Glick","year":"1988","journal-title":"J. Pediatr. Surg."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/nyas.14443","article-title":"Complement factors and alpha-fetoprotein as biomarkers for noninvasive prenatal diagnosis of neural tube defects","volume":"1478","author":"Dong","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_74","first-page":"651","article-title":"Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects","volume":"2","author":"Wald","year":"1979","journal-title":"Lancet"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(75)91495-6","article-title":"Alpha-fetoprotein in antenatal diagnosis of congenital nephrosis","volume":"1","author":"Kjessler","year":"1975","journal-title":"Lancet Lond. Engl."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.21608\/smj.2020.24854.1109","article-title":"Alpha-feto protein in obstetrics","volume":"24","author":"Elrahim","year":"2020","journal-title":"Sohag Med. J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/153537020422900602","article-title":"Biological roles of alpha-fetoprotein during pregnancy and perinatal development","volume":"229","author":"Mizejewski","year":"2004","journal-title":"Exp. Biol. Med."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Houwelingen, L.V., Sandoval, J.A., Houwelingen, L.V., and Sandoval, J.A. (2016). Alpha-Fetoprotein in Malignant Pediatric Conditions. Proof and Concepts in Rapid Diagnostic Tests and Technologies, IntechOpen.","DOI":"10.5772\/63911"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/gyno.1999.5653","article-title":"\u03b1-Fetoprotein Production by a Malignant Mixed M\u00fcllerian Tumor of the Ovary","volume":"77","author":"Rebischung","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1399-0004.1987.tb03349.x","article-title":"Type III congenital cystic adenomatoid malformation of the lung: Another cause of elevated alpha fetoprotein?","volume":"32","author":"Petit","year":"1987","journal-title":"Clin. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Maton\u00f3g, A., and Drosdzol-Cop, A. (2024). Alpha-fetoprotein level in fetuses, infants, and children with ovarian masses: A literature review. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1307619"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00383-007-2067-7","article-title":"Elevated serum alpha-fetoprotein in Wilms tumor may follow the same pattern of other fetal neoplasms after treatment: Evidence from three cases","volume":"24","author":"Crocoli","year":"2008","journal-title":"Pediatr. Surg. Int."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/14767050410001668257","article-title":"Preliminary estimate for the second-trimester maternal serum screening detection rate of the 45,X karyotype using alpha-fetoprotein, unconjugated estriol and human chorionic gonadotropin","volume":"15","author":"Benn","year":"2004","journal-title":"J. Matern.-Fetal Neonatal Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0002-9378(84)90530-1","article-title":"An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities","volume":"148","author":"Merkatz","year":"1984","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e111917","DOI":"10.5812\/mejrh.111917","article-title":"Evaluation of Second-Trimester Maternal Serum AFP Value in the Detection of Congenital Heart Defects","volume":"8","author":"Aghaamoo","year":"2021","journal-title":"Middle East J. Rehabil. Health Stud."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa040963","article-title":"Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome","volume":"351","author":"Smith","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0301-2115(03)00081-2","article-title":"Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy","volume":"110","author":"Duric","year":"2003","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1701-2163(16)32973-5","article-title":"RETIRED: Obstetrical Complications Associated with Abnormal Maternal Serum Markers Analytes","volume":"30","author":"Gagnon","year":"2008","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_89","first-page":"2621","article-title":"Correlation between elevated maternal serum alpha-fetoprotein, certain pregnancy complications and fetal death","volume":"133","author":"Pejtsik","year":"1992","journal-title":"Orv. Hetil."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/jp.2015.40","article-title":"Maternal serum markers, characteristics and morbidly adherent placenta in women with previa","volume":"35","author":"Lyell","year":"2015","journal-title":"J. Perinatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"278","DOI":"10.22578\/IJMS.20.2.16","article-title":"Maternal Serum Alpha Feto Protein Level May Predict Morbidly Adherent Placenta in Women with Placenta Previa","volume":"20","author":"Hassan","year":"2022","journal-title":"Iraqi J. Med. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/AOG.0000000000001889","article-title":"First-Trimester and Second-Trimester Maternal Serum Biomarkers as Predictors of Placental Abruption","volume":"129","author":"Ananth","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"675","DOI":"10.12998\/wjcc.v6.i13.675","article-title":"Possible connection between elevated serum \u03b1-fetoprotein and placental necrosis during pregnancy: A case report and review of literature","volume":"6","author":"Yu","year":"2018","journal-title":"World J. Clin. Cases"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1515\/jpm-2016-0101","article-title":"Pregnancy outcomes regarding maternal serum AFP value in second trimester screening","volume":"45","author":"Bartkute","year":"2017","journal-title":"J. Perinat. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"738","DOI":"10.30574\/wjarr.2023.18.3.1158","article-title":"The role of maternal serum alpha-fetoprotein in preterm birth: A literature review","volume":"18","author":"Zahra","year":"2023","journal-title":"World J. Adv. Res. Rev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejogrb.2009.04.017","article-title":"Is elevated maternal serum alpha-fetoprotein in the second trimester of pregnancy associated with increased preterm birth risk?: A systematic review and meta-analysis","volume":"145","author":"Yuan","year":"2009","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"921","DOI":"10.7754\/Clin.Lab.2016.161103","article-title":"Maternal Serum PLGF, PAPPA, \u03b2-hCG and AFP Levels in Early Second Trimester as Predictors of Preeclampsia","volume":"63","author":"Duan","year":"2017","journal-title":"Clin. Lab."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pcl.2018.12.009","article-title":"Intrauterine Growth Restriction: Postnatal Monitoring and Outcomes","volume":"66","author":"Kesavan","year":"2019","journal-title":"Pediatr. Clin. N. Am."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-2006-947724","article-title":"Evaluating the Thresholds of Abnormal Second Trimester Multiple Marker Screening Tests Associated with Intra-Uterine Growth Restriction","volume":"23","author":"Odibo","year":"2006","journal-title":"Am. J. Perinatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.placenta.2019.04.005","article-title":"The association between first trimester AFP to PAPP-A ratio and placentally-related adverse pregnancy outcome","volume":"81","author":"Hughes","year":"2019","journal-title":"Placenta"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/pd.6454","article-title":"Prenatal diagnosis and postnatal outcome of closed spinal dysraphism","volume":"44","author":"Bedei","year":"2024","journal-title":"Prenat. Diagn."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1471-0528.2008.01700.x","article-title":"Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down\u2019s syndrome","volume":"115","author":"Boyd","year":"2008","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_103","first-page":"248","article-title":"Value Analysis of Four-Dimensional Color Ultrasound Combined with Maternal Serological Index in Prenatal Screening for Fetal Anomalies","volume":"30","author":"Lu","year":"2024","journal-title":"Altern. Ther. Health Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.siny.2017.11.005","article-title":"First and second trimester screening for fetal structural anomalies","volume":"23","author":"Edwards","year":"2018","journal-title":"Semin. Fetal. Neonatal Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.semperi.2005.05.011","article-title":"Second Trimester Serum Markers","volume":"29","author":"Canick","year":"2005","journal-title":"Semin. Perinatol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cca.2020.10.029","article-title":"Serum markers in quadruple screening associated with adverse pregnancy outcomes: A case\u2013control study in China","volume":"511","author":"Yue","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.metabol.2017.07.004","article-title":"Performance of first trimester biochemical markers and mean arterial pressure in prediction of early-onset pre-eclampsia","volume":"75","author":"Nevalainen","year":"2017","journal-title":"Metab. Clin. Exp."},{"key":"ref_108","first-page":"e23115","article-title":"Prediction of Pregnancy Complications with Maternal Biochemical Markers Used in Down Syndrome Screening","volume":"14","author":"Ozdemir","year":"2022","journal-title":"Cureus"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Zhang, T., and Wang, S. (2022). Potential Serum Biomarkers in Prenatal Diagnosis of Placenta Accreta Spectrum. Front. Med., 9.","DOI":"10.3389\/fmed.2022.860186"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5812\/ijem.5014","article-title":"Mid-Trimester Maternal Serum hCG and Alpha Fetal Protein Levels: Clinical Significance and Prediction of Adverse Pregnancy Outcome","volume":"11","author":"Androutsopoulos","year":"2013","journal-title":"Int. J. Endocrinol. Metab."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0002-9378(99)70334-0","article-title":"Second-trimester maternal serum marker screening: Maternal serum \u03b1-fetoprotein, \u03b2-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome","volume":"181","author":"Yaron","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s13224-021-01508-8","article-title":"Association Between Serum Markers Used in the Routine Prenatal Screening with Pregnancy Outcomes: A Cohort Study","volume":"72","year":"2022","journal-title":"J. Obstet. Gynaecol. India"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"023002","DOI":"10.1088\/2516-1091\/ad3a4b","article-title":"Ultrasound imaging based recognition of prenatal anomalies: A systematic clinical engineering review","volume":"6","author":"Sriraam","year":"2024","journal-title":"Prog. Biomed. Eng."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejogrb.2021.01.008","article-title":"Non invasive prenatal testing (NIPT) for common aneuploidies and beyond","volume":"258","author":"Alberry","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0020-7292(03)00390-4","article-title":"ACOG practice bulletin. Neural tube defects. Number 44, July 2003. (Replaces committee opinion number 252, March 2001)","volume":"83","author":"Cheschier","year":"2003","journal-title":"Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"(2017). Practice Bulletin No. 187: Neural Tube Defects. Obstet. Gynecol., 130, e279\u2013e290.","DOI":"10.1097\/AOG.0000000000002412"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics, Committee on Genetics, and Society for Maternal-Fetal Medicine (2020). Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet. Gynecol., 136, e48\u2013e69.","DOI":"10.1097\/AOG.0000000000004084"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/jgc4.1165","article-title":"Variations in prenatal screening in a US federal healthcare system: Same coverage, different options","volume":"28","author":"Thagard","year":"2019","journal-title":"J. Genet. Couns."},{"key":"ref_120","first-page":"2303","article-title":"Limited Role of MSAFP Screening for Prenatal Omphalocele Detection","volume":"43","author":"Parobek","year":"2024","journal-title":"J. Ultrasound Med. Off. J. Am. Inst. Ultrasound Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13089-023-00314-9","article-title":"Geographic varia-tion in point of care ultrasound provision: Results from a national audit","volume":"15","author":"Aggarwal","year":"2023","journal-title":"Ultrasound J."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5468\/ogs.22263","article-title":"Prenatal screening for neural tube defects: From maternal serum alpha-fetoprotein to ultrasonography","volume":"66","author":"Kim","year":"2023","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Lust, E.E.R., Bronsgeest, K., Henneman, L., Crombag, N., Bilardo, C.M., Galjaard, R.-J.H., Sikkel, E., van der Hout, S., Coumans, A., and Elvan-Ta\u015fp\u0131nar, A. (2025). Introduction of a nationwide first-trimester anomaly scan in the Dutch national screening program. Am. J. Obstet. Gynecol., 232.","DOI":"10.1016\/j.ajog.2024.07.026"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.AOG.0000174581.24338.6f","article-title":"A cost-effectiveness analysis of prenatal screening strategies for Down syndrome","volume":"106","author":"Odibo","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"61ra91","DOI":"10.1126\/scitranslmed.3001720","article-title":"Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus","volume":"2","author":"Lo","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Huang, Q., Xu, Q., Chen, M., Fan, W., and Huang, H. (2025). Application of non-invasive prenatal testing for fetal chromosomal disorders in low-risk pregnancies: A follow-up study in central China. Front. Genet., 16.","DOI":"10.3389\/fgene.2025.1574775"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Zaninovi\u0107, L., Ba\u0161kovi\u0107, M., Je\u017eek, D., and Katu\u0161i\u0107 Bojanac, A. (2022). Validity and Utility of Non-Invasive Prenatal Testing for Copy Number Variations and Microdeletions: A Systematic Review. J. Clin. Med., 11.","DOI":"10.3390\/jcm11123350"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Sun, X., Ying, Y., Chen, C., and Shi, X. (2025). Cell-free DNA screening for trisomies 21, 18, and 13: Clinical application and accuracy evaluation. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0332081"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"12859","DOI":"10.1038\/s41598-025-97230-w","article-title":"Retrospective study on NIPT or NIPT plus combined with ultrasound in screening fetal chromosomal abnormalities","volume":"15","author":"Chen","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1748-5908-1-16","article-title":"Barriers and facilitators to implementing shared decision-making in clinical practice: A systematic review of health professionals\u2019 perceptions","volume":"1","author":"Gravel","year":"2006","journal-title":"Implement. Sci. IS"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Oxenford, K., Daley, R., Lewis, C., Hill, M., and Chitty, L.S. (2017). Development and evaluation of training resources to prepare health professionals for counselling pregnant women about non-invasive prenatal testing for Down syndrome: A mixed methods study. BMC Pregnancy Childbirth, 17.","DOI":"10.1186\/s12884-017-1315-7"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/pd.6043","article-title":"Non-invasive prenatal test uptake in socioeconomically disadvantaged neighborhoods","volume":"41","author":"Kooij","year":"2021","journal-title":"Prenat. Diagn."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Carbone, L., Cariati, F., Sarno, L., Conforti, A., Bagnulo, F., Strina, I., Pastore, L., Maruotti, G.M., and Alviggi, C. (2020). Non-Invasive Prenatal Testing: Current Perspectives and Future Challenges. Genes, 12.","DOI":"10.3390\/genes12010015"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/IJWH.S67124","article-title":"Non-invasive prenatal testing: A review of international implementation and challenges","volume":"7","author":"Allyse","year":"2015","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/pd.4511","article-title":"A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome","volume":"35","author":"Walker","year":"2015","journal-title":"Prenat. Diagn."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/aogs.13841","article-title":"Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation","volume":"99","author":"Petersen","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/uog.20284","article-title":"Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: Update of The Fetal Medicine Foundation results and meta-analysis","volume":"53","author":"Gil","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/ejhg.2015.57","article-title":"Non-invasive prenatal testing for aneuploidy and beyond: Challenges of responsible innovation in prenatal screening","volume":"23","author":"Dondorp","year":"2015","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/uog.70015","article-title":"Performance of non-invasive prenatal testing in vanishing-twin and multiple pregnancies: Results of TRIDENT-2 study","volume":"66","author":"Bax","year":"2025","journal-title":"Ultrasound Obstet. Gynecol."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/5\/534\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:44:53Z","timestamp":1779288293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/5\/534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":139,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["cimb48050534"],"URL":"https:\/\/doi.org\/10.3390\/cimb48050534","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}